日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Results of the ACCOuNT Trial: A Multi-Institutional Prospective Pharmacogenomics Implementation Trial for African American Inpatients

ACCOuNT试验结果:一项针对非裔美国住院患者的多中心前瞻性药物基因组学实施试验

Huang, Zhong; O'Leary, Kevin J; Nutescu, Edith A; Jack, Matthew; Chen, Thomas; Ruhnke, Gregory W; Lee, James C; George, David; House, Larry K; Knoebel, Randall; Rasmussen, Luke V; Hartman, Seth; Choksi, Anish; Yeo, Kiang-Teck J; Perera, Minoli A; Ratain, Mark J; Meltzer, David O; O'Donnell, Peter H

Evaluating Perceived Value of Pharmacogenomic Testing After a Personalized Therapeutics Clinic Consultation

在个性化治疗诊所咨询后评估药物基因组学检测的感知价值

Chen, Thomas; Andriessen, Amanda S; Jack, Matthew; George, David; House, Larry K; Chan, Clarence; Yeo, Kiang-Teck J; Ratain, Mark J; O'Donnell, Peter H

Totality of the Evidence: Optimizing Dosage Selection Strategies in Oncology

综合所有证据:优化肿瘤剂量选择策略

Levit, Laura A; Shah, Mirat; Ratain, Mark J; Garrett-Mayer, Elizabeth; Rahman, Atiqur; Theoret, Marc; Harvey, R Donald

Impact of First-of-Its-Kind Patient-Facing Pharmacogenetics Tool on Dosing Decisions and Treatment Outcomes

首个面向患者的药物遗传学工具对剂量决策和治疗结果的影响

Cho, Youngwoo; Elahi, Sami; Jack, Matthew M; Campbell, John; Smith, Emily; Knoebel, Randall W; George, David; House, Larry; Yeo, Kiang-Teck J; Karrison, Theodore; Volchenboum, Samuel L; Meltzer, David O; Szmulewitz, Russell Z; Vokes, Everett E; Ratain, Mark J; O'Donnell, Peter H

Strengthening the Food and Drug Administration Office of Clinical Pharmacology's Labeling Authority

加强美国食品药品监督管理局临床药理学办公室的标签审批权限

Ratain, Mark J; Strohbehn, Garth W

Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy

基于转录组因果网络的基因特征可对结直肠癌患者进行分层,以便进行有效的靶向治疗。

Yazdani, Akram; Lenz, Heinz-Josef; Pillonetto, Gianluigi; Mendez-Giraldez, Raul; Yazdani, Azam; Sanoff, Hanna; Hadi, Reza; Samiei, Esmat; Venook, Alan P; Ratain, Mark J; Rashid, Naim; Vincent, Benjamin G; Qu, Xueping; Wen, Yujia; Kosorok, Michael; Symmans, William F; Shen, John Paul Y C; Lee, Michael S; Kopetz, Scott; Nixon, Andrew B; Bertagnolli, Monica M; Perou, Charles M; Innocenti, Federico

An Ethical and Financial Obligation for Sickle Cell Disease Gene Therapy in the United States

美国对镰状细胞病基因疗法的伦理和经济义务

Wesevich, Austin; Peek, Monica E; Ratain, Mark J

Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance)

长链非编码RNA基因的常见变异会调节转移性结直肠癌患者循环TGF-β2水平的变化(Alliance)

Quintanilha, Julia C F; Sibley, Alexander B; Liu, Yingmiao; Niedzwiecki, Donna; Halabi, Susan; Rogers, Layne; O'Neil, Bert; Kindler, Hedy; Kelly, William; Venook, Alan; McLeod, Howard L; Ratain, Mark J; Nixon, Andrew B; Innocenti, Federico; Owzar, Kouros

Project Optimus: Is the US Food and Drug Administration Waiving Dose Optimization for Orphan Drugs?

Optimus 项目:美国食品药品监督管理局是否豁免孤儿药的剂量优化?

Wesevich, Austin; Ratain, Mark J

Gene signatures derived from transcriptomic-causal networks stratified colorectal cancer patients for effective targeted therapy

基于转录组因果网络构建的基因特征可对结直肠癌患者进行分层,从而实现有效的靶向治疗。

Yazdani, Akram; Lenz, Heinz-Josef; Pillonetto, Gianluigi; Mendez-Giraldez, Raul; Yazdani, Azam; Sanof, Hanna; Hadi, Reza; Samiei, Esmat; Venook, Alan P; Ratain, Mark J; Rashid, Naim; Vincent, Benjamin G; Qu, Xueping; Wen, Yujia; Kosorok, Michael; Symmans, William F; Shen, John Paul Y C; Lee, Michael S; Kopetz, Scott; Nixon, Andrew B; Bertagnolli, Monica M; Perou, Charles M; Innocenti, Federico